Cargando…
Identification of plasma biomarker candidates in glioblastoma using an antibody-array-based proteomic approach
BACKGROUND: Glioblastoma multiforme (GBM) is a brain tumour with a very high patient mortality rate, with a median survival of 47 weeks. This might be improved by the identification of novel diagnostic, prognostic and predictive therapy-response biomarkers, preferentially through the monitoring of t...
Autores principales: | Zupancic, Klemen, Blejec, Andrej, Herman, Ana, Veber, Matija, Verbovsek, Urska, Korsic, Marjan, Knezevic, Miomir, Rozman, Primoz, Turnsek, Tamara Lah, Gruden, Kristina, Motaln, Helena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Versita, Warsaw
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110082/ https://www.ncbi.nlm.nih.gov/pubmed/25177240 http://dx.doi.org/10.2478/raon-2014-0014 |
Ejemplares similares
-
Analysis of Glioblastoma Patients' Plasma Revealed the Presence of MicroRNAs with a Prognostic Impact on Survival and Those of Viral Origin
por: Herman, Ana, et al.
Publicado: (2015) -
Transmembrane protein CD9 is glioblastoma biomarker, relevant for maintenance of glioblastoma stem cells
por: Podergajs, Neža, et al.
Publicado: (2015) -
Expression Analysis of All Protease Genes Reveals Cathepsin K to Be Overexpressed in Glioblastoma
por: Verbovšek, Urška, et al.
Publicado: (2014) -
Correction: Expression Analysis of All Protease Genes Reveals Cathepsin K to Be Overexpressed in Glioblastoma
por: Verbovšek, Urška, et al.
Publicado: (2015) -
A “Crossomics” Study Analysing Variability of Different Components in Peripheral Blood of Healthy Caucasoid Individuals
por: Gruden, Kristina, et al.
Publicado: (2012)